Shirley Lecher
A5044717103- HIV/AIDS Research and Interventions
- HIV, Drug Use, Sexual Risk
- HIV-related health complications and treatments
- HIV Research and Treatment
- Healthcare and Environmental Waste Management
- COVID-19 Impact on Reproduction
- Viral Infections and Outbreaks Research
Centers for Disease Control and Prevention
2024
Center for Global Health
2024
Lesotho Planned Parenthood Association
2022
Office of Science
2016
Center for Surveillance, Epidemiology, and Laboratory Services
2016
United States Department of Health and Human Services
2016
Abstract Introduction Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt antiretroviral (ARV) therapy among aware and viral load (VL) suppression those on ARVs, respectively, critical. However, few data from sub‐Saharan Africa (SSA) are available older people (50+) living with (OPLWH). We examined progress age, 15–49 (as a comparison) 50+ years, further analyses (55–59, 60–64, 65+ vs. 50–54), in 13 countries (Cameroon,...
Pediatric human immunodeficiency virus (HIV) infection remains an important public health issue in resource-limited settings. In 2015, 1.4 million children aged <15 years were estimated to be living with HIV (including 170,000 infants born 2015), the vast majority sub-Saharan Africa (1). 2014, 150,000 died from HIV-related causes worldwide (2). Access timely diagnosis and treatment for HIV-infected reduces HIV-associated mortality, which is approximately 50% by age 2 without (3). Since 2011,...
As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, programmes require up-to-date information about evolving risk behaviour and transmission risk, including those low-level viremia (LLV; >50 to ≤1000 copies/mL), guide prevention priorities. We aimed assess differences in sexual behaviours, distribution of viral load (VL) proportion across PLHIV subgroups. analysed data from Population-based Impact Assessment surveys 14 sub-Saharan African countries...
Introduction: Waste generated from HIV viral load testing and SARS CoV-2 for diagnosis of COVID-19 contains potentially hazardous guanidinium thiocyanate. Guanidinium thiocyanate may be toxic to humans if not properly disposed can pollute waters harm aquatic life. Sub-Saharan African countries are particularly challenged by limited resources suitably manage waste at health care facilities laboratories. There is a need identify management challenges develop strategies mitigate this type...
The early period of the COVID-19 pandemic limited access to HIV services for children and adolescents living with (C/ALHIV). To determine progress in providing care treatment services, we describe viral load coverage (VLC) suppression (VLS) (<1000 copies/ mL) rates during 12 United States President’s Emergency Plan AIDS Relief (PEPFAR)-supported countries. Data (0–9 years) (10–19 on VLC VLS were analyzed sub-Saharan African (SSA) countries between 2019 (pre-COVID-19) 2020 (during...